Human brain cells, classified into different groups according to gene expression (each color represents a group), are mapped back to their original locations in the human brain

Genes That Grow a Healthy Brain Could Fuel Adult Glioblastoma

The discovery of a new type of stem cell in the brain could usher in better treatments for the deadliest brain tumor.

Breast Cancer Risk Could be Determined in Seconds: Artificial Intelligence

Imagine a future where your annual mammogram isn't just a routine check-up but a personalized assessment of your breast cancer risk.

Year in Review: 2024

As the year winds down, we take a moment to reflect on some of our milestones from this year.

In Memoriam: Felix Feng, MD

This week, UCSF lost a cherished friend and colleague with the passing of Felix Feng, MD. His legacy will live on through the many lives he touched and the impact of his work.

Believe It or Not, 1 Vape is the Same as Smoking 30 Cigarettes

UCSF is home to the world’s largest archive of Big Tobacco’s internal documents. Meet the physician deciphering its pages to uncover how marketing is creating a new epidemic.

Microplastic particles on the fingertips of an open hand

Microplastics in the Air May Be Leading to Lung and Colon Cancers

A review of 3,000 studies also suggests these minute plastic air particles may be causing male and female infertility.

3D rendering showing immune proteins delivering K R A S, and others a radioactive antibody, to a tumor cell." class="element-fade element-fade--in-viewport

How This Cancer Drug Could Make Radiation a Slam Dunk Therapy

UCSF scientists have combined a precision drug therapy with an antibody and radiation to eliminate tumors without causing side effects.

Wendell Lim, PhD, examines models of molecules that instruct immune cells to kill cancer cells.

Engineered Immune Cells May Be Able to Tame Inflammation

Immune cells that are designed to soothe could improve treatment for organ transplants, type 1 diabetes and other autoimmune conditions.

A graphic illustration depicting programmed killer T cells

Molecular Zip Code Draws Killer T Cells to Brain Tumors

Researchers programmed immune cells to attack glioblastoma and treat inflammation from multiple sclerosis in mice. The glioblastoma technology will soon be tested in a clinical trial.

How this ‘Switchable’ CAR-T Therapy Sets its Sights on Deadly Brain Cancer

Invented at UCSF, this smarter gene therapy is revolutionizing the field of precision cancer care and may, one day, cure the deadliest form of brain cancer.

Alan Ashworth UCSF Cancer Center president and BRCA Researcher

Thirty years since the race to the BRCA1 gene

The isolation of the BRCA1 gene 30 years ago ushered in the era of genetic testing for breast and other cancers, launched a long-lasting patent battle and eventually led to a tailored cancer therapy.